US · Healthcare

Bright Minds Biosciences Inc (DRUG)

Biotechnology

Bright Minds Biosciences Inc (DRUG) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DRUG

P/E ratio

18.00

Bright Minds Biosciences Inc (DRUG) — FAQ

What is DRUG's P/E ratio?

The price-to-earnings (P/E) ratio for Bright Minds Biosciences Inc (DRUG) is 18.00 (data as of 2026-03-24).

Does Bright Minds Biosciences Inc pay a dividend?

Dividend yield is not available in the current snapshot for Bright Minds Biosciences Inc (DRUG). Check the MyAverix Finance app for the latest dividend data.

What sector is Bright Minds Biosciences Inc in?

Bright Minds Biosciences Inc (DRUG) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DRUG listed on?

DRUG is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)